An Evaluation of Drug-Induced Blood Pressure Changes in a Standard Canine CV Safety Pharmacology Study: A HESI-sponsored consortium, Koshman et al., P26. Presented by Yevgeniya Koshman, AbbVie
In Vitro Assessment of Long-Term Cardiotoxicity Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes, Kettenhofen et al. P107. Presented by Ralf Kettenhofen, Fraunhofer IBMT
Development of a Pharmaceutical Database to support the Nonclinical Evaluation of Drug-Induced Cardiac Toxicity, De Alwis et al., P138. Presented by Jennifer Pierson, HESI
Heart Rate Corrected JTp and TpTe as Proarrhythmia Biomarkers in Safety Pharmacology Non-Human Primate Studies: Outcome from a HESI Consortium Prospective Study, Authier et al.,P025. Presented by Todd Wisialowski, Pfizer
The Impact of Collaborative Science on Cardiovascular Safety Evaluation – A 10-Year Update of the HESI Cardiac Safety Committee, Blinova et al., P140. Presented by Jennifer Pierson & Claire O'Brien, HESI
Privacy & Cookies Policy
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.